Recent Press Releases

WASHINGTON, D.C. – Senate Republican Leader Mitch McConnell, joined by Sens. Orrin Hatch (R-UT) and Tom Coburn (R-OK), today urged the Department of Health and Human Services (HHS) Inspector General (IG) to carefully examine recent reports that the government may be paying incorrect Obamacare subsidies as the IG prepares to submit a mandated report to Congress by July 1.

In a letter to HHS IG Daniel R. Levinson, the lawmakers wrote that outgoing HHS Secretary Kathleen Sebelius may have incorrectly certified that the Obamacare exchanges verify that individuals receiving tax credits and cost-sharing assistance are actually eligible to accept those taxpayer-provided subsidies.

Sebelius certified to Congress in January that the exchanges could confirm that subsidy applicants are eligible to receive the benefits, and she detailed a number of measures that were supposed to be in place to protect the taxpayer. Congress passed a law that requires the HHS IG to issue a report by July 1 of this year evaluating the effectiveness of safeguards to prevent improper payments.

But a number of reports, including a recent story in The Washington Post and testimony from the Treasury Department’s IG for Tax Administration, indicate that many of the systems needed to ensure verification have yet to be built or used.  The Washington Post reported earlier this month that the government may be paying incorrect Obamacare subsidies to more than 1 million Americans for their health plans because the computer system capability that would match proof with the application hasn’t yet been built. The Treasury IG testified last month that some of the systems needed to prevent improper or fraudulent payments had not been completed, tested or deployed.

“These reports call into serious question the veracity of the Secretary’s certification that Exchanges will accurately verify an applicant’s eligibility for subsidies before they were issued,” wrote McConnell and Hatch, who is the ranking Republican on the Senate Finance Committee, and Coburn, the ranking member of the Senate Homeland Security & Governmental Affairs Committee. “It seems highly unlikely that the Secretary could accurately certify that systems were in place to verify the accuracy of applicant information, when in fact these systems had not been fully developed, tested, and deployed.” 

The lawmakers said they would “strongly encourage” the IG as he prepares his July 1 report, to carefully examine the media reports and Treasury IG testimony when evaluating the effectiveness of the procedures and safeguards the Secretary certified.

“Whatever one’s opinion of Obamacare, the American public deserves to know that their tax dollars are allocated appropriately and that public officials take their responsibility to accurately and faithfully apply the laws enacted by Congress seriously,” the lawmakers wrote.

Read the letter here.

LOUISVILLE, KY -- U.S. Senate Republican Leader Mitch McConnell made the following comments regarding Kentucky’s Department of Agriculture getting its first shipment of hemp seeds:

“I want to congratulate Commissioner Comer for his delivery today, and applaud Senator Paul for his hard work on helping make this happen. Now that the seeds have been freed, it’s time to get them in the ground and begin our lawful pilot programs to explore the potential for job creation in our Commonwealth.”

McConnell sponsors Sunscreen Innovation Act

Urges FDA to Expedite Approval of Innovative Sunscreen More Effective Against Cancer-Causing UVA Rays; Precursor Ingredients Manufactured in Kentucky

May 23, 2014

Washington, D.C. – U.S. Senate Republican Leader Mitch McConnell co-sponsored the Sunscreen Innovation Act, which would ensure sunscreen ingredients receive a timely and transparent review by the Food and Drug Administration (FDA).  Skin cancer is the most common form of cancer in the country, and a known contributor to developing skin cancer is over exposure to ultraviolet (UV) radiation.  Despite this public health threat, the FDA has failed to review new sunscreen ingredient applications that include technologies more capable of protecting skin against harmful UVA rays for more than a decade.  These same technologies in pending U.S. sunscreen ingredient applications are available in Europe and other countries overseas, and in some cases have been so for more than 15 years. 

“This is another example of bureaucracy run amok.  It is unacceptable that FDA has been sitting on pending applications since 2002 that have the potential to provide greater protections to American families looking forward to spending some time in the sun this Memorial Day Weekend, and throughout the summer.  I applaud my friend and colleague, Congressman Ed Whitfield, for his leadership in introducing a companion bill in the House, and I look forward to working with him and my Senate colleagues to fix this regulatory obstacle,” Senator McConnell said. 

Ashland Inc., a global specialty chemical company with a facility in Calvert City, manufactures precursor ingredients for these innovative sunscreens, and the cosmetics and beauty company, L’Oréal, has a finished product manufacturing facility in Florence. L’Oréal has two sunscreen ingredients pending approval, but they have been held up by the backlog at FDA.

“Ashland Inc. appreciates Senator McConnell's support for the Sunscreen Innovation Act. This important legislation will enable Ashland and other ingredient manufacturers to provide consumers with a choice of safe, effective sunscreens,” said James Mish, who leads Ashland Inc.'s consumer specialties division. “We have a product with a proven benefit to consumers and this bill would establish a clear pathway for these products to be reviewed quickly and thoroughly. In addition to benefiting the citizens of Kentucky by providing them with the latest technology in sunscreens, passage of this bill will benefit the local economy as products manufactured at the Ashland Calvert City plant are used in the final process. It is expected that access to the US market will significantly increase the demand for all of these products.”

“As a proud Kentucky employer and pioneer in skincare innovation since inventing the first sunscreen in 1936, L’Oréal commends Senator Mitch McConnell’s decision to cosponsor the Sunscreen Innovation Act, which will provide American consumers greater access to the newest, safe and effective sunscreen products available,” said Kristina Schake, Chief Communications Officer of L’Oréal USA.